Skip over main navigation
  • Log in
  • Basket: (0 items)
Hadassah Australia Medical Research Collaboration (HAMRC)
  • Facebook
  • Instagram
Donate
Menu
  • About us
    • Who we are
    • Vision, Mission, Purpose
    • Israel
    • Our team
      • Board
      • Scientific Advisory Committee
      • Development Committee
      • Staff
  • Research
    • Current research
    • Need for collaborative research
    • Partnering with Israel
    • Research partnerships
  • Our impact
    • The difference we can make together
    • Year In Review 2020 - Hadassah Australia
  • Get involved
    • Donate
    • Other ways to give
      • Pledge Gifts
      • Gifts in Wills
    • Project Enquiries
  • News and events
    • News
    • Upcoming Events
    • Webinars
    • Current newsletter
  • Admin
    • Log in
  • Basket: (0 items)

Development Committee

Our project facilitators help to advocate projects for philanthropic investments in addition to the in-house development and philanthropy team members at HAMRC and Hadassah Australia.


Dug Pomeroy - Chair

Dug Pomeroy is the founder and Executive Chairman of Pomeroy Pacific Pty Ltd. Founded in 1971, the Pomeroy Group of Companies has an extensive background in Development Services, Project Management, Construction Management and Property Investment.


Jacqueline Pascarl

Jacqueline Pascarl is a multi-lingual, high-profile expert consultant who served five years as the first female National Vice Chair of the Australian Defence Forces (Reserves) Executive. She is an award-winning documentary producer and prominent lobbyist on human rights, women’s rights, and refugee issues. Jacqueline has raised over $40 million for the NFP sector.


Dr Phillip Brenner

Dr Phillip Brenner was previously head of St Vincents urology unit in Sydney, New South Wales. A practicing urological surgeon for well over 20 years, Dr. Brenner specialized in treating patients with urological cancers, with a particular emphasis on treating cancer of the prostate as well as cancer of the kidneys.


Alan Liddle

Alan Liddle has over 30 years' experience in developing and commercialising medical and biological therapeutics and over 30 years’ research & executive management experience in the medical and the biotechnology research sector encompassing immunology and bio-therapeutics for cancer and auto-immune diseases, cardiology, neuroplasticity, the microbiome, regenerative medicine & rehabilitation.


Peter Marks

Peter brings over 30 years’ experience in corporate advisory, investment banking and director/advisory roles to the committee. With several leading firms, Peter’s corporate skills lie in capital raising for pre-IPO and listed companies, cross border M&A transactions, corporate underwriting, and venture capital transactions for companies in Australia, US & Israel.

Published: 7th November, 2019

Updated: 8th February, 2021

Author: Lee Robinson

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Year In Review 2020

    Year In Review 2020

    In a year of anxiety and stress globally and in our own community, 2020 was a year in which Hadassah Australia reaffirmed its commitment to support the Hadassah Medical Organization in its vision to shape the future of Jerusalem, Israel and the global community.

  • Second International Conference on Trauma and Mental Health

    Second International Conference on Trauma and Mental Health

    Explore the key issues faced by psychologists, psychiatrists, GPs, social workers, counsellors and others dealing with patients or clients affected by adversity and trauma.

  • Alan Liddle - Chair

  • A journey into the future of health

    A journey into the future of health

    An innovative series of live virtual events to explore the future frontiers of Medicine, featuring some of Hadassah's top visionaries from Jerusalem’s two world-renowned hospitals. Presented by Hadassah International.

Most read

  • At risk: Exploring the link between prematurity and chronic kidney disease

    At risk: Exploring the link between prematurity and chronic kidney disease

    Catch up on this important webinar bringing you expert and personal insights on the link between prematurity and chronic kidney disease.

  • Enlivex reports top-line results for Allocetra™ in treating Covid-19

    Enlivex reports top-line results for Allocetra™ in treating Covid-19

    Enlivex has reported positive top-line results from phase ii clinical trial evaluating Allocetra in severe and critical Covid-19 patients and provides a program update

  • Researching a way forward

    Researching a way forward

    “We have a chance to do something significant in the medical field because of the calibre of people who are attracted to the work we do,” says Dr Russell Basser, Chair of the HAMRC Scientific Advisory Committee.

  • Israel: The Connection

    Israel: The Connection

    There is virtually no area of medical research to which Israel has not made significant contributions - cardiology, genetics, neurology and ophthalmology are but a few that have benefited.

  • Vision, mission, purpose

    Vision, mission, purpose

    The HAMRC Foundation links the brightest researchers at Hadassah Hospital in Israel with their colleagues in Australia in order to solve the most pressing health issues facing the world.

  • Our board

    Our board

    The board oversees HAMRC’s mission including the assessment and funding of high-quality medical research collaborations which will ultimately lead to improve patient outcomes by accelerating the pace of biomedical discovery and the translation of medical breakthroughs into novel therapeutics and diagnostics.

  • Webinar—Coping with COVID: Safeguarding your mental health in the age of COVID-19

    Webinar—Coping with COVID: Safeguarding your mental health in the age of COVID-19

    Register now for this live webinar bringing you expert tips and insights from some of Australia and Israel's leading mental health professionals.

  • Drug developed by Hadassah doctor helps severely ill Covid-19 patients

    Drug developed by Hadassah doctor helps severely ill Covid-19 patients

    Hadassah Hospital successfully treated five seriously-ill COVID-19 patients using an experimental treatment. All five patients tested negative to coronavirus and have now been discharged.

  • Save the Next Steve Jobs from Terminal Pancreatic Cancer

    Save the Next Steve Jobs from Terminal Pancreatic Cancer

    Save the next Steve Jobs from terminal pancreatic cancer; harness Australia's medical know-how and Israel's clinical trial advantage.

  • Example - Where your money goes

    Earn your supporters' trust by being transparent and making the impact of their support clear

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Find us

Registered Office
PO Box 2400
Caulfield
Vic 3161

+61 (3) 9272 5600
[email protected]

Links

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Follow us

  • Facebook
  • Instagram

Registered as Charity number 90629423641